CN1323214A - 阴离子型或阳离子型树枝状聚合物抗微生物或抗寄生物的组合物 - Google Patents

阴离子型或阳离子型树枝状聚合物抗微生物或抗寄生物的组合物 Download PDF

Info

Publication number
CN1323214A
CN1323214A CN99812270A CN99812270A CN1323214A CN 1323214 A CN1323214 A CN 1323214A CN 99812270 A CN99812270 A CN 99812270A CN 99812270 A CN99812270 A CN 99812270A CN 1323214 A CN1323214 A CN 1323214A
Authority
CN
China
Prior art keywords
dendritic
acid
end capped
solution
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99812270A
Other languages
English (en)
Chinese (zh)
Inventor
B·R·马休斯
G·霍兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Starpharma Pty Ltd
Original Assignee
Starpharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Starpharma Pty Ltd filed Critical Starpharma Pty Ltd
Publication of CN1323214A publication Critical patent/CN1323214A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/16—Dendrimers and dendritic polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN99812270A 1998-09-14 1999-09-13 阴离子型或阳离子型树枝状聚合物抗微生物或抗寄生物的组合物 Pending CN1323214A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP5842 1998-09-14
AUPP5842A AUPP584298A0 (en) 1998-09-14 1998-09-14 Antimicrobial and antiparasitic agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNA2008100874448A Division CN101352451A (zh) 1998-09-14 1999-09-13 阴离子型或阳离子型树枝状聚合物抗微生物或抗寄生物的组合物

Publications (1)

Publication Number Publication Date
CN1323214A true CN1323214A (zh) 2001-11-21

Family

ID=3810064

Family Applications (2)

Application Number Title Priority Date Filing Date
CN99812270A Pending CN1323214A (zh) 1998-09-14 1999-09-13 阴离子型或阳离子型树枝状聚合物抗微生物或抗寄生物的组合物
CNA2008100874448A Pending CN101352451A (zh) 1998-09-14 1999-09-13 阴离子型或阳离子型树枝状聚合物抗微生物或抗寄生物的组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA2008100874448A Pending CN101352451A (zh) 1998-09-14 1999-09-13 阴离子型或阳离子型树枝状聚合物抗微生物或抗寄生物的组合物

Country Status (12)

Country Link
US (1) US6464971B1 (cg-RX-API-DMAC7.html)
EP (1) EP1113806B1 (cg-RX-API-DMAC7.html)
JP (1) JP4979848B2 (cg-RX-API-DMAC7.html)
KR (1) KR100720905B1 (cg-RX-API-DMAC7.html)
CN (2) CN1323214A (cg-RX-API-DMAC7.html)
AT (1) ATE372123T1 (cg-RX-API-DMAC7.html)
AU (1) AUPP584298A0 (cg-RX-API-DMAC7.html)
BR (1) BR9913712A (cg-RX-API-DMAC7.html)
CA (1) CA2343113C (cg-RX-API-DMAC7.html)
DE (1) DE69937059T2 (cg-RX-API-DMAC7.html)
NZ (1) NZ510289A (cg-RX-API-DMAC7.html)
WO (1) WO2000015240A1 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1296711C (zh) * 2004-05-14 2007-01-24 沈阳迈迪生物医学技术有限公司 乳腺癌的Her-2免疫组织化学诊断试剂盒
CN1902263B (zh) * 2003-11-24 2011-07-27 罗狄亚英国有限公司 具有单膦酸端基的新型树枝状聚合物,其制备方法和用途
CN114053392A (zh) * 2020-07-30 2022-02-18 广州朗圣药业有限公司 新型化合物在制备预防和/或治疗hpv感染的药物中的应用

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572459B2 (en) * 1998-09-14 2009-08-11 Starpharma Pty Ltd. Anionic or cationic dendrimer antimicrobial or antiparasitic compositions
KR100413532B1 (ko) * 2001-02-14 2003-12-31 학교법인 포항공과대학교 폴리아민이 말단에 치환된 덴드리머 및 그 제조방법
AUPR412801A0 (en) 2001-03-30 2001-05-03 Starpharma Limited Agent for the prevention and treatment of sexually transmitted disease s - I
AUPR412901A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agents for the prevention and treatment of sexually transmitted disease s - II
MXPA04005611A (es) * 2001-12-11 2005-04-19 Cellgate Inc Reactivos y conjugados de transporte de guanidinio.
US20050271615A1 (en) * 2002-08-30 2005-12-08 Doron Shabat Self-immolative dendrimers releasing many active moieties upon a single activating event
US20040234496A1 (en) * 2003-02-06 2004-11-25 Stockel Richard F. Biocidal compositions
US7074459B2 (en) * 2003-05-23 2006-07-11 Stockel Richard F Method for preserving wood
FR2862651B1 (fr) * 2003-11-24 2006-03-31 Rhodia Cons Spec Ltd Nouveaux dendrimeres a terminaisons bisphosphoniques et derives, leur procede de preparation et leur utilisation
JP4553354B2 (ja) * 2004-10-04 2010-09-29 正隆 井原 抗トリパノソーマ剤
US8790672B2 (en) * 2005-02-22 2014-07-29 Nina M. Lamba-Kohli Generation of antimicrobial surfaces using dendrimer biocides
US20060269480A1 (en) * 2005-05-31 2006-11-30 Ramot At Tel Aviv University Ltd. Multi-triggered self-immolative dendritic compounds
CA2612211A1 (en) * 2005-07-08 2007-01-18 Janssen Pharmaceutica N.V. Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors
JP5213718B2 (ja) * 2005-10-18 2013-06-19 スターファーマ・プロプライエタリー・リミテッド 殺微生物性デンドリマー組成物のデリバリーシステム
WO2007045010A1 (en) * 2005-10-21 2007-04-26 Starpharma Pty Limited Inhibitory compounds
EP1973587B1 (en) * 2005-12-12 2019-02-06 AllAccem, Inc. Methods and systems for preparing antimicrobial films and coatings
WO2007082331A1 (en) * 2006-01-20 2007-07-26 Starpharma Pty Limited Modified macromolecule
AU2007229268B2 (en) 2006-03-22 2013-01-10 Starpharma Pty Limited Contraceptive composition
AU2008218275B2 (en) 2007-02-21 2013-06-20 Allaccem, Incorporated Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
US20080282480A1 (en) * 2007-05-15 2008-11-20 The Hong Kong Polytechnic University Multifunction Finishing Liquids Containing Dendrimers and the Application of the Liquids in Textile Finishing
WO2009045237A1 (en) * 2007-05-21 2009-04-09 California Institute Of Technology Extraction of actinides from mixtures and ores using dendritic macromolecules
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels
US20100008864A1 (en) * 2008-07-10 2010-01-14 Andreas Meijer Aromatic multimers
US9815712B2 (en) 2008-10-03 2017-11-14 California Institute Of Technology High capacity perchlorate-selective resins from hyperbranched macromolecules
WO2010040117A2 (en) * 2008-10-03 2010-04-08 California Institute Of Technology Extraction of anions from solutions and mixtures using hyperbranched macromolecules
WO2011001657A1 (ja) 2009-07-01 2011-01-06 独立行政法人科学技術振興機構 ポリイオンデンドリマー、及びそれよりなるハイドロゲル
JP5212656B2 (ja) * 2009-09-02 2013-06-19 日産化学工業株式会社 イソチオシアナト化合物の製造方法
US8658702B2 (en) 2009-12-17 2014-02-25 Mamadou Diallo Soluble anion exchangers from hyperbranched macromolecules
WO2012012049A2 (en) * 2010-06-30 2012-01-26 Huiwen Liu Antimicrobial complexes
RU2478106C2 (ru) * 2010-11-25 2013-03-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) СОЕДИНЕНИЯ НА ОСНОВЕ КОМПЛЕКСОВ ГИПЕРРАЗВЕТВЛЕННЫХ ПОЛИМЕРОВ Boltorn H, ОБЛАДАЮЩИЕ АНТИКАНДИДОЗНОЙ АКТИВНОСТЬЮ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
EP2647623A4 (en) 2010-11-29 2015-12-30 Nissan Chemical Ind Ltd METHOD FOR PRODUCING AN ISOTHIOCYANATE COMPOUND
HUE047170T2 (hu) * 2011-05-16 2020-04-28 Starpharma Pty Ltd Bakteriális vaginózis kezelési vagy megelõzési módszere
US8962662B2 (en) 2011-11-15 2015-02-24 Byocoat Enterprises, Inc. Antimicrobial compositions and methods of use thereof
WO2014043576A1 (en) * 2012-09-13 2014-03-20 Starpharma Pty Limited Method of treatment or prophylaxis of infections of the eye
EP2958429A4 (en) * 2013-02-20 2016-10-05 Biolog Inc COMPOSITIONS AND METHODS FOR INACTIVATION AND / OR REDUCTION OF MICROBIAL TOXIN PRODUCTION
EP2970586B1 (en) * 2013-03-15 2022-12-07 Genzyme Corporation Amine functional polyamides
GB201405660D0 (en) * 2014-03-28 2014-05-14 Gama Healthcare Ltd A liquid disinfecting composition
CN103999853B (zh) * 2014-06-11 2015-07-22 中国农业大学 荧光树枝状纳米大分子在制备药物载体中的应用
US9854806B2 (en) 2015-05-19 2018-01-02 International Business Machines Corporation Antimicrobial guanidinium and thiouronium functionalized polymers
CA3020634C (en) * 2016-04-14 2025-06-17 Genzyme Corporation MULTIDOSE COMPOSITIONS CONTAINING AN ANTIMICROBIAL PRESERVATIVE BASED ON POLYAMIDE OR OCTENIDINE
WO2018081845A1 (en) 2016-11-02 2018-05-11 The University Of Melbourne Antibacterial compositions and methods
US11154589B2 (en) 2016-11-02 2021-10-26 The University Of Melbourne Antimicrobial composition combinations comprising star shaped peptide polymers
US10953039B2 (en) 2018-09-27 2021-03-23 International Business Machines Corporation Utilizing polymers and antibiotics to enhance antimicrobial activity and inhibit antibiotic resistance
CN110041523B (zh) * 2019-04-15 2021-04-30 同济大学 低代树枝状聚赖氨酸类抗菌肽及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
US5658574A (en) 1995-10-13 1997-08-19 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cleansing compositions with dendrimers as mildness agents
DE19624705A1 (de) 1996-06-20 1998-01-08 Deutsches Krebsforsch Dendrimere auf Saccharid-Basis
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
AU5610198A (en) 1996-12-19 1998-07-15 Penn State Research Foundation, The Compounds and methods for treating and preventing bacterial and viral disease
AUPP584398A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Inhibition of toxic materials or substances

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1902263B (zh) * 2003-11-24 2011-07-27 罗狄亚英国有限公司 具有单膦酸端基的新型树枝状聚合物,其制备方法和用途
CN1296711C (zh) * 2004-05-14 2007-01-24 沈阳迈迪生物医学技术有限公司 乳腺癌的Her-2免疫组织化学诊断试剂盒
CN114053392A (zh) * 2020-07-30 2022-02-18 广州朗圣药业有限公司 新型化合物在制备预防和/或治疗hpv感染的药物中的应用

Also Published As

Publication number Publication date
KR100720905B1 (ko) 2007-05-25
CA2343113C (en) 2009-11-24
WO2000015240A1 (en) 2000-03-23
EP1113806B1 (en) 2007-09-05
ATE372123T1 (de) 2007-09-15
CN101352451A (zh) 2009-01-28
AUPP584298A0 (en) 1998-10-08
JP2002524524A (ja) 2002-08-06
KR20010075066A (ko) 2001-08-09
JP4979848B2 (ja) 2012-07-18
EP1113806A1 (en) 2001-07-11
DE69937059T2 (de) 2008-05-29
DE69937059D1 (de) 2007-10-18
EP1113806A4 (en) 2003-06-25
NZ510289A (en) 2002-10-25
CA2343113A1 (en) 2000-03-23
BR9913712A (pt) 2001-05-29
US6464971B1 (en) 2002-10-15

Similar Documents

Publication Publication Date Title
CN1161128C (zh) 抑制血管生成的化合物
KR100720905B1 (ko) 음이온성 또는 양이온성 덴드리머의 항균성 또는 구충성조성물
CN1134486C (zh) 抗病毒树枝状体
CN1168735C (zh) 核苷单磷酸酯脂类酯及其做为免疫抑制药物的应用
CN1227034C (zh) 药物复合物的制造方法
CN1503664A (zh) 以两亲共聚物为基础的纳米粒子的胶体悬液
US20090124832A1 (en) Oligoamine compounds and derivatives thereof for cancer therapy
CN1354740A (zh) 药用化合物
CN1035923C (zh) 制备亲脂寡糖抗生素盐组合物的方法
CN1056056A (zh) 控制胆固醇的组合物及其控制方法
WO2011139348A9 (en) Uses of phospholipid conjugates of synthetic tlr7 agonists
CN86104185A (zh) N-(2-氨基酰氨基-2-去氧-己糖基)-酰胺类、氨基甲酸酯类和一脲类的制备工艺及其医药用途
CN1180697A (zh) 用于基因治疗的阳离子类脂
CN1227499A (zh) 药物复合物
CN1323215A (zh) 使用树枝状聚合物抑制毒物或毒性物质
CN1762990A (zh) 包含氨基氧基的化合价平台分子
CN1543465A (zh) 用作选择性细菌dhfr抑制剂的新的杂环化合物及其应用
CN107033186B (zh) 泊沙康唑衍生物、其药物组合物和用途
CN1083068A (zh) 16节环抗菌的大环内酯的衍生物
CN101065409A (zh) 交联胺聚合物
CN1867580A (zh) 被甘油衍生物修饰的化合物
KR20170028979A (ko) 주쇄 폴리아민
CN1212123C (zh) 脂肪结合聚合物
CN1373770A (zh) 假单胞菌素前药
WO2021117770A1 (ja) 医薬組成物及び処置剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication